BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26751192)

  • 1. Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study Group.
    van Leeuwaarde RS; van Nesselrooij BP; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Vriens MR; de Laat JM; Pieterman CR; Valk GD
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1159-65. PubMed ID: 26751192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel MEN1 germline mutations in Brazilian families with multiple endocrine neoplasia type 1.
    Toledo RA; Lourenço DM; Coutinho FL; Quedas E; Mackowiack I; Machado MC; Montenegro F; Cunha-Neto MB; Liberman B; Pereira MA; Correa PH; Toledo SP
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):377-84. PubMed ID: 17555499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
    Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple endocrine neoplasia type 1 (MEN1) in Austria.
    Weinhäusel A; Kaserer K; Vierhapper H; Niederle B; Haas OA;
    Wien Klin Wochenschr; 2002 Apr; 114(7):252-7. PubMed ID: 12089860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1).
    Lairmore TC; Piersall LD; DeBenedetti MK; Dilley WG; Mutch MG; Whelan AJ; Zehnbauer B
    Ann Surg; 2004 May; 239(5):637-45; discussion 645-7. PubMed ID: 15082967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database.
    Giusti F; Cianferotti L; Boaretto F; Cetani F; Cioppi F; Colao A; Davì MV; Faggiano A; Fanciulli G; Ferolla P; Ferone D; Fossi C; Giudici F; Gronchi G; Loli P; Mantero F; Marcocci C; Marini F; Masi L; Opocher G; Beck-Peccoz P; Persani L; Scillitani A; Sciortino G; Spada A; Tomassetti P; Tonelli F; Brandi ML
    Endocrine; 2017 Nov; 58(2):349-359. PubMed ID: 28132167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile.
    Lourenço DM; Toledo RA; Mackowiak II; Coutinho FL; Cavalcanti MG; Correia-Deur JE; Montenegro F; Siqueira SA; Margarido LC; Machado MC; Toledo SP
    Eur J Endocrinol; 2008 Sep; 159(3):259-74. PubMed ID: 18524795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database.
    Sakurai A; Suzuki S; Kosugi S; Okamoto T; Uchino S; Miya A; Imai T; Kaji H; Komoto I; Miura D; Yamada M; Uruno T; Horiuchi K; Miyauchi A; Imamura M; ; Fukushima T; Hanazaki K; Hirakawa S; Igarashi T; Iwatani T; Kammori M; Katabami T; Katai M; Kikumori T; Kiribayashi K; Koizumi S; Midorikawa S; Miyabe R; Munekage T; Ozawa A; Shimizu K; Sugitani I; Takeyama H; Yamazaki M
    Clin Endocrinol (Oxf); 2012 Apr; 76(4):533-9. PubMed ID: 21950691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
    Gaztambide S; Vazquez F; Castaño L
    Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients.
    de Laat JM; van der Luijt RB; Pieterman CR; Oostveen MP; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Vriens MR; Valk GD
    BMC Med; 2016 Nov; 14(1):182. PubMed ID: 27842554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing.
    Ellard S; Hattersley AT; Brewer CM; Vaidya B
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):169-75. PubMed ID: 15670192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic screening for MEN1 mutations in families presenting with familial primary hyperparathyroidism.
    Perrier ND; Villablanca A; Larsson C; Wong M; Ituarte P; Teh BT; Clark OH
    World J Surg; 2002 Aug; 26(8):907-13. PubMed ID: 12016470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1.
    Lourenço DM; Toledo RA; Coutinho FL; Margarido LC; Siqueira SA; dos Santos MA; Montenegro FL; Machado MC; Toledo SP
    Clinics (Sao Paulo); 2007 Aug; 62(4):465-76. PubMed ID: 17823710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.
    Machens A; Schaaf L; Karges W; Frank-Raue K; Bartsch DK; Rothmund M; Schneyer U; Goretzki P; Raue F; Dralle H
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):613-22. PubMed ID: 17590169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 10 Swiss kindreds with multiple endocrine neoplasia type 1: assessment of screening methods.
    Clerici T; Schmid C; Komminoth P; Lange J; Spinas GA; Brändle M
    Swiss Med Wkly; 2001 Jun; 131(25-26):381-6. PubMed ID: 11524904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of the Danish families with multiple endocrine neoplasia type 1.
    Jäger AC; Friis-Hansen L; Hansen TV; Eskildsen PC; Sølling K; Knigge U; Hansen CP; Andersen PH; Brixen K; Feldt-Rasmussen U; Kroustrup JP; Mollerup CL; Rehfeld JF; Blichert-Toft M; Nielsen FC
    Mol Cell Endocrinol; 2006 Apr; 249(1-2):123-32. PubMed ID: 16563611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Germline c.105_107dupGCT
    Stasiak M; Dedecjus M; Zawadzka-Starczewska K; Adamska E; Tomaszewska M; Lewiński A
    Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32847108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the p27 rs2066827 variant and tumor multiplicity in patients harboring MEN1 germline mutations.
    Longuini VC; Lourenço DM; Sekiya T; Meirelles O; Goncalves TD; Coutinho FL; Francisco G; Osaki LH; Chammas R; Alves VA; Siqueira SA; Schlesinger D; Naslavsky MS; Zatz M; Duarte YA; Lebrão ML; Gama P; Lee M; Molatore S; Pereira MA; Jallad RS; Bronstein MD; Cunha-Neto MB; Liberman B; Fragoso MC; Toledo SP; Pellegata NS; Toledo RA
    Eur J Endocrinol; 2014 Sep; 171(3):335-42. PubMed ID: 24920291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UMD-MEN1 Database: An Overview of the 370 MEN1 Variants Present in 1676 Patients From the French Population.
    Romanet P; Mohamed A; Giraud S; Odou MF; North MO; Pertuit M; Pasmant E; Coppin L; Guien C; Calender A; Borson-Chazot F; Béroud C; Goudet P; Barlier A
    J Clin Endocrinol Metab; 2019 Mar; 104(3):753-764. PubMed ID: 30339208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.
    Balogh K; Hunyady L; Patocs A; Gergics P; Valkusz Z; Toth M; Racz K
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):727-34. PubMed ID: 17953629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.